Medicines play a major role in treating and curing infections and managing chronic conditions like high blood pressure, high ...

This special report investigates the alarming deaths of children in India and abroad due to contaminated, Indian-made cough ...

India has refused drugmakers' requests to extend a year-end deadline to upgrade manufacturing facilities, amid public anger ...

NEW DELHI (Reuters) -Indian pharmaceutical firms failed to follow rules that every batch of medicinal ingredients is tested, ...

Trade conflict escalates as the US plans 100 per cent tariffs on Chinese exports. Could Indian exporters gain a strategic ...

The White House has decided not to impose tariffs on generic drug imports, providing relief to Indian pharmaceutical ...

Indian pharmaceutical companies eye Russian market for production facilities, aiming to strengthen bilateral cooperation in ...

Union Minister of State (Independent Charge) for Science and Technology, Jitendra Singh on Saturday (18 October) said that ...

This story is part of Forbes’ coverage of India’s Richest 2025. See the full list here.

The deal values JB Pharma at around $3 billion, which instantly makes this step one of the biggest takeovers in India’s ...

It is merely the latest, most horrific symptom in a continuing and distressingly predictable series of regulatory failures ...

Mounjaro, originally developed as a diabetes drug, has skyrocketed to become India’s no. 2 pharma brand, thanks to a booming ...